cariporide has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arranz, JL; Cardone, RA; Fais, S; Harguindey, S; Polo Orozco, JD; Rauch, C; Reshkin, SJ | 1 |
| Grant, DS; Owen, CS; Wahl, ML | 1 |
1 review(s) available for cariporide and Neoplasms
| Article | Year |
|---|---|
Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
Topics: Antineoplastic Agents; Cation Transport Proteins; Guanidines; Humans; Hydrogen-Ion Concentration; Neoplasms; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfones | 2013 |
1 other study(ies) available for cariporide and Neoplasms
| Article | Year |
|---|---|
Angiostatin induces intracellular acidosis and anoikis in endothelial cells at a tumor-like low pH.
Topics: Acidosis; Angiostatins; Animals; Anoikis; Cells, Cultured; Endothelium, Vascular; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Fluid; Neoplasms; Peptide Fragments; Plasminogen; Rats; Sulfones | 2002 |